scientific article published on 17 March 2018

AttributesValues
rdf:type
description
  • wetenschappelijk artikel (nl)
  • scientific article published on 17 March 2018 (en)
  • article scientifique publié en 2018 (fr)
  • artículu científicu espublizáu en marzu de 2018 (ast)
  • наукова стаття, опублікована 17 березня 2018 (uk)
publication date
publication date
author name string
author name string
  • Ying He
  • Michael Meister
  • Thomas Muley
  • Farshid Dayyani
  • Arne Warth
  • Hendrik Dienemann
  • Felix J Herth
  • Marc A Schneider
  • Birgit Wehnl
  • Vinzent Rolny
  • Achim Escherich
  • Christa Stolp
rdfs:label
  • The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC) (en)
  • The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC) (nl)
skos:prefLabel
  • The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC) (en)
  • The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC) (nl)
name
  • The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC) (en)
  • The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC) (nl)
title
title
  • The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC) (en)
page(s)
page(s)
  • 46-53
instance of
instance of
main subject
main subject
PubMed ID
PubMed ID
PubMed ID
  • 29748014
published in
published in
volume
volume
  • 120
DOI
DOI
DOI
  • 10.1016/J.LUNGCAN.2018.03.015
is about of
is cites work of
is cites work of
Faceted Search & Find service v1.16.117 as of May 05 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software